The global enteric empty capsules market is on a robust growth trajectory, poised to expand from US$ 3.1 billion in 2025 to US$ 4.6 billion by 2032, exhibiting a steady CAGR of 6.0% during the forecast period. These capsules, primarily designed to protect sensitive drugs from the acidic environment of the stomach, play a crucial role in enhancing the efficacy and safety of oral drug administration. They offer targeted delivery to the intestines, ensuring effective absorption and minimizing gastric side effects. As gastrointestinal disorders continue to rise globally, particularly among the aging population, the demand for enteric capsules is surging across both pharmaceutical and nutraceutical industries.
According to insights from Persistence Market Research, North America is expected to lead the global market in 2025, driven by the region’s high burden of digestive diseases and advanced pharmaceutical infrastructure. The pharmaceutical segment, which held a dominant 68.70% market share in 2024, continues to lead in adoption, supported by clinical research investments and a growing demand for targeted, controlled-release therapeutics. The gelatin capsules segment, accounting for 61.40% share in 2024, remains at the forefront due to its broad utility in protecting acid-sensitive drugs and maintaining dosage integrity.
Key Highlights from the Report:
• The global market is projected to grow from US$ 3.1 Bn in 2025 to US$ 4.6 Bn by 2032.
• Gelatin capsules held the largest market share of 61.40% in 2024.
• The nutraceutical segment is expected to capture 32.79% of the market by 2025.
• North America will dominate with over 42.4% share in 2025.
• Pharmaceutical industry continues to lead in end-user segment with 68.70% share.
• Growing GI disorder cases among elderly populations are propelling market growth.
Get a Sample Copy of Research Report (Use Corporate Mail id for Quick Response):
https://www.persistencemarketresearch.com/samples/34728
Market Segmentation:
The enteric empty capsules market is segmented based on product type into gelatin capsules, hydroxypropyl methylcellulose (HPMC) capsules, and vegetable capsules. Gelatin capsules dominate due to their affordability, high compatibility with various drugs, and excellent protection for acid-sensitive formulations. These capsules are especially preferred in mainstream pharmaceuticals for delivering drugs that degrade in stomach acid, enhancing patient safety and drug bioavailability. However, vegetable-based and HPMC capsules are gaining popularity due to rising consumer awareness about plant-based alternatives and religious or dietary restrictions surrounding gelatin.
In terms of end-users, the market is segmented into the pharmaceutical industry, nutraceutical industry, and others. The pharmaceutical sector leads the market, fueled by technological innovation, stringent regulatory approvals, and the growing incidence of chronic diseases requiring targeted therapies. Meanwhile, the nutraceutical industry is rapidly gaining ground, using enteric capsules for supplements like probiotics, herbal extracts, and digestive enzymes, especially in regions like Asia Pacific and Europe, where preventive health and natural remedies are becoming popular.
Regional Insights:
North America Trends
North America is expected to maintain a dominant position in the enteric empty capsules market through 2032, supported by a growing number of clinical trials and product approvals aimed at treating gastrointestinal disorders. The region benefits from a high prevalence of GI conditions, advanced manufacturing capabilities, and a strong regulatory framework that fosters innovation in drug delivery systems.
Europe Trends
Europe is seeing rising adoption of enteric capsules due to the pharmaceutical industry’s strong focus on patient-centric drug delivery and compliance with rigorous regulatory standards. Increasing preference for clean-label, vegetarian capsule formulations is encouraging European firms to invest in non-gelatin enteric alternatives, contributing to market diversification and innovation.
Market Drivers:
One of the primary drivers of the enteric empty capsules market is the growing prevalence of gastrointestinal disorders, especially among the elderly population. A 2021 global study revealed that over 40% of adults experience functional GI disorders such as irritable bowel syndrome and acid reflux. Enteric capsules provide a reliable method to deliver treatments directly to the intestines, reducing irritation and improving absorption. Moreover, rising interest in controlled-release drug delivery systems among pharmaceutical firms is bolstering demand for advanced enteric formulations.
Market Restraints
Despite the market’s growth potential, adoption barriers persist due to consumer preferences shifting toward plant-based alternatives. The predominant use of gelatin—an animal-derived material—in capsule production is misaligned with the values of vegetarians, vegans, and religious groups that avoid animal-based ingredients. Furthermore, supply chain challenges related to gelatin sourcing and quality maintenance increase operational costs for manufacturers. These factors could limit adoption and require firms to innovate with non-animal alternatives.
Market Opportunities
Significant opportunities lie in technological advancements in capsule manufacturing. Innovations such as precision-targeted coatings, time-released delivery, and AI-assisted personalization are allowing companies to create more sophisticated and effective products. The introduction of machines like ACG’s personalized capsule manufacturing equipment in 2025 is paving the way for customized solutions in both pharmaceuticals and nutraceuticals. Additionally, rising consumer awareness about GI health and functional supplements is opening up new avenues in emerging markets.
Reasons to Buy the Report:
• Gain in-depth insights into market dynamics, trends, and growth drivers influencing the enteric capsule industry.
• Understand segmentation by product type and end-user to identify key investment opportunities.
• Evaluate regional trends across North America, Europe, and Asia Pacific to identify geographic growth hubs.
• Access competitive intelligence and recent innovations shaping the market.
• Stay updated on major product launches, mergers, and technological advancements in the field.
Frequently Asked Questions (FAQs):
• How big is the global enteric empty capsules market?
• Who are the key players in the global enteric empty capsules market?
• What is the projected growth rate of the market from 2025 to 2032?
• What is the market forecast for enteric empty capsules by 2032?
• Which region is estimated to dominate the industry through the forecast period?
Company Insights:
The global enteric empty capsules market features several prominent players striving to differentiate themselves through innovation, acquisitions, and strategic collaborations. Key companies include:
• Lonza
• Roquette Frères
• SUHEUNG
• Farmacápsulas
• Nectar Lifesciences Ltd.
• ZHEJIANG HUILI CAPSULES CO., LTD
• Shaoxing Zhongya Capsule Co., Ltd.
• Chemcaps Limited
• Fortcaps
• Natural Capsules Limited
Recent Developments:
In May 2024, researchers published a breakthrough study in Molecular Pharmaceutics, showcasing enteric-coated capsules tailored for drug release in the distal ileum—an area vital for immune activation.
In November 2022, Lonza Group unveiled Enprotec Capsules, engineered to deliver acid-sensitive active pharmaceutical ingredients (APIs) without the need for additional coatings, reducing production time and cost.
Conclusion
The enteric empty capsules market is poised for significant transformation over the coming decade. As demand for targeted drug delivery continues to rise, manufacturers must adapt to evolving consumer preferences, invest in sustainable alternatives to gelatin, and leverage new technologies to improve drug efficacy. Regions like North America and Asia Pacific will serve as major growth engines, driven by strong healthcare infrastructure and rising public health awareness. With pharmaceutical and nutraceutical companies actively investing in innovation, this market presents lucrative opportunities for stakeholders committed to redefining the standards of oral drug delivery.
As Persistence Market Research outlines, the next decade will be critical for market players to capitalize on emerging trends, improve product sustainability, and expand into untapped territories. Whether driven by aging populations, chronic disease prevalence, or consumer shifts toward natural remedies, the future of enteric empty capsules lies in technological advancement, global expansion, and personalized medicine.
Read Related Reports:
Enzyme Replacement Therapy Market
Artificial Blood Vessels Market
